{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:06:26Z","timestamp":1791331586147,"version":"4.3.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T00:00:00Z","timestamp":1408665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00277-014-2173-2","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T05:32:27Z","timestamp":1408599147000},"page":"79-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["High APRIL but not BAFF serum levels are associated with poor outcome in patients with follicular lymphoma"],"prefix":"10.1007","volume":"94","author":[{"given":"Ya-Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Jun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Yong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Qi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,22]]},"reference":[{"issue":"8","key":"2173_CR1","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","volume":"16","author":"JO Armitage","year":"1998","unstructured":"Armitage JO, Weisenburger DD (1998) New approach to classifying non-Hodgkin\u2019s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin\u2019s Lymphoma Classification Project. J Clin Oncol 16(8):2780\u20132795","journal-title":"J Clin Oncol"},{"issue":"12","key":"2173_CR2","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V99.12.4265","volume":"99","author":"JJ Biagi","year":"2002","unstructured":"Biagi JJ, Seymour JF (2002) Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood 99(12):4265\u20134275","journal-title":"Blood"},{"issue":"Suppl 7","key":"2173_CR3","doi-asserted-by":"crossref","first-page":"vii151","DOI":"10.1093\/annonc\/mdq287","volume":"21","author":"M Ghielmini","year":"2010","unstructured":"Ghielmini M (2010) Follicular lymphoma. Ann Oncol 21(Suppl 7):vii151\u2013vii153","journal-title":"Ann Oncol"},{"issue":"5","key":"2173_CR4","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-Celigny","year":"2004","unstructured":"Solal-Celigny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, Au WY, Bellei M, Brice P, Caballero D, Coiffier B, Conde-Garcia E, Doyen C, Federico M, Fisher RI, Garcia-Conde JF, Guglielmi C, Hagenbeek A, Haioun C, LeBlanc M, Lister AT, Lopez-Guillermo A, McLaughlin P, Milpied N, Morel P, Mounier N, Proctor SJ, Rohatiner A, Smith P, Soubeyran P, Tilly H, Vitolo U, Zinzani PL, Zucca E, Montserrat E (2004) Follicular lymphoma international prognostic index. Blood 104(5):1258\u20131265","journal-title":"Blood"},{"issue":"27","key":"2173_CR5","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","volume":"27","author":"M Federico","year":"2009","unstructured":"Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, Pro B, Pileri S, Pulsoni A, Soubeyran P, Cortelazzo S, Martinelli G, Martelli M, Rigacci L, Arcaini L, Di Raimondo F, Merli F, Sabattini E, McLaughlin P, Solal-Celigny P (2009) Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 27(27):4555\u20134562","journal-title":"J Clin Oncol"},{"issue":"5425","key":"2173_CR6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1126\/science.285.5425.260","volume":"285","author":"PA Moore","year":"1999","unstructured":"Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li Y, Galperina O, Giri J, Roschke V, Nardelli B, Carrell J, Sosnovtseva S, Greenfield W, Ruben SM, Olsen HS, Fikes J, Hilbert DM (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285(5425):260\u2013263","journal-title":"Science"},{"issue":"11","key":"2173_CR7","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","volume":"189","author":"P Schneider","year":"1999","unstructured":"Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, Tschopp J (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189(11):1747\u20131756","journal-title":"J Exp Med"},{"issue":"6781","key":"2173_CR8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35010115","volume":"404","author":"JA Gross","year":"2000","unstructured":"Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W, Clegg CH (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404(6781):995\u2013999","journal-title":"Nature"},{"issue":"5537","key":"2173_CR9","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1126\/science.1061965","volume":"293","author":"JS Thompson","year":"2001","unstructured":"Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, Hession C, Schneider P, Sizing ID, Mullen C, Strauch K, Zafari M, Benjamin CD, Tschopp J, Browning JL, Ambrose C (2001) BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293(5537):2108\u20132111","journal-title":"Science"},{"issue":"8","key":"2173_CR10","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2002-02-0558","volume":"100","author":"AJ Novak","year":"2002","unstructured":"Novak AJ, Bram RJ, Kay NE, Jelinek DF (2002) Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood 100(8):2973\u20132979","journal-title":"Blood"},{"issue":"5","key":"2173_CR11","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.4049\/jimmunol.172.5.3268","volume":"172","author":"B He","year":"2004","unstructured":"He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, Cerutti A (2004) Lymphoma B cells evade apoptosis through the TNF family members BAFF\/BLyS and APRIL. J Immunol 172(5):3268\u20133279","journal-title":"J Immunol"},{"issue":"2","key":"2173_CR12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1182\/blood-2003-02-0540","volume":"103","author":"C Kern","year":"2004","unstructured":"Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, Stenou V, Defrance T, Ajchenbaum-Cymbalista F, Simonin PY, Feldblum S, Kolb JP (2004) Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 103(2):679\u2013688","journal-title":"Blood"},{"issue":"5","key":"2173_CR13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2006.04.004","volume":"18","author":"SG Tangye","year":"2006","unstructured":"Tangye SG, Bryant VL, Cuss AK, Good KL (2006) BAFF, APRIL and human B cell disorders. Semin Immunol 18(5):305\u2013317","journal-title":"Semin Immunol"},{"issue":"6","key":"2173_CR14","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1084\/jem.188.6.1185","volume":"188","author":"M Hahne","year":"1998","unstructured":"Hahne M, Kataoka T, Schroter M, Hofmann K, Irmler M, Bodmer JL, Schneider P, Bornand T, Holler N, French LE, Sordat B, Rimoldi D, Tschopp J (1998) APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 188(6):1185\u20131190","journal-title":"J Exp Med"},{"issue":"8","key":"2173_CR15","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1182\/blood-2004-02-0762","volume":"104","author":"AJ Novak","year":"2004","unstructured":"Novak AJ, Grote DM, Stenson M, Ziesmer SC, Witzig TE, Habermann TM, Harder B, Ristow KM, Bram RJ, Jelinek DF, Gross JA, Ansell SM (2004) Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood 104(8):2247\u20132253","journal-title":"Blood"},{"issue":"2","key":"2173_CR16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3324\/haematol.10678","volume":"92","author":"Y Oki","year":"2007","unstructured":"Oki Y, Georgakis GV, Migone TS, Kwak LW, Younes A (2007) Prognostic significance of serum B-lymphocyte stimulator in Hodgkin\u2019s lymphoma. Haematologica 92(2):269\u2013270","journal-title":"Haematologica"},{"issue":"9","key":"2173_CR17","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3324\/haematol.10317","volume":"92","author":"L Planelles","year":"2007","unstructured":"Planelles L, Castillo-Gutierrez S, Medema JP, Morales-Luque A, Merle-Beral H, Hahne M (2007) APRIL but not BLyS serum levels are increased in chronic lymphocytic leukemia: prognostic relevance of APRIL for survival. Haematologica 92(9):1284\u20131285","journal-title":"Haematologica"},{"issue":"6","key":"2173_CR18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2141.2007.06615.x","volume":"137","author":"C Tecchio","year":"2007","unstructured":"Tecchio C, Nadali G, Scapini P, Bonetto C, Visco C, Tamassia N, Vassilakopoulos TP, Pangalis GA, Calzetti F, Nardelli B, Roschke V, Gottardi M, Zampieri F, Gherlinzoni F, Facchetti F, Pizzolo G, Cassatella MA (2007) High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma. Br J Haematol 137(6):553\u2013559","journal-title":"Br J Haematol"},{"issue":"3","key":"2173_CR19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0609.2008.01099.x","volume":"81","author":"SJ Kim","year":"2008","unstructured":"Kim SJ, Lee SJ, Choi IY, Park Y, Choi CW, Kim IS, Yu W, Hwang HS, Kim BS (2008) Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy. Eur J Haematol 81(3):177\u2013184","journal-title":"Eur J Haematol"},{"issue":"2","key":"2173_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ajh.21328","volume":"84","author":"SM Ansell","year":"2009","unstructured":"Ansell SM, Novak AJ, Ziesmer S, Price-Troska T, LaPlant B, Dillon SR, Witzig TE (2009) Serum BLyS levels increase after rituximab as initial therapy in patients with follicular grade 1 non-Hodgkin lymphoma. Am J Hematol 84(2):71\u201373","journal-title":"Am J Hematol"},{"issue":"8","key":"2173_CR21","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood-2003-06-1984","volume":"103","author":"J Moreaux","year":"2004","unstructured":"Moreaux J, Legouffe E, Jourdan E, Quittet P, Reme T, Lugagne C, Moine P, Rossi JF, Klein B, Tarte K (2004) BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 103(8):3148\u20133157","journal-title":"Blood"},{"key":"2173_CR22","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon, France","edition":"4"},{"issue":"4","key":"2173_CR23","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17(4):1244","journal-title":"J Clin Oncol"},{"issue":"2","key":"2173_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-472X(01)00774-3","volume":"30","author":"J Briones","year":"2002","unstructured":"Briones J, Timmerman JM, Hilbert DM, Levy R (2002) BLyS and BLyS receptor expression in non-Hodgkin\u2019s lymphoma. Exp Hematol 30(2):135\u2013141","journal-title":"Exp Hematol"},{"issue":"9","key":"2173_CR25","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1080\/10428190701549562","volume":"48","author":"Y Oki","year":"2007","unstructured":"Oki Y, Georgakis GV, Migone TS, Kwak LW, Younes A (2007) Elevated serum BLyS levels in patients with non-Hodgkin lymphoma. Leuk Lymphoma 48(9):1869\u20131871","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2173_CR26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1200\/JCO.2005.02.7938","volume":"24","author":"AJ Novak","year":"2006","unstructured":"Novak AJ, Grote DM, Ziesmer SC, Kline MP, Manske MK, Slager S, Witzig TE, Shanafelt T, Call TG, Kay NE, Jelinek DF, Cerhan JR, Gross JA, Harder B, Dillon SR, Ansell SM (2006) Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders. J Clin Oncol 24(6):983\u2013987","journal-title":"J Clin Oncol"},{"issue":"1","key":"2173_CR27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.leukres.2008.05.004","volume":"33","author":"S Molica","year":"2009","unstructured":"Molica S, Digiesi G, Mauro F, Mirabelli R, Cutrona G, Vitelli G, Morabito F, Iuliano F, Foa R, Ferrarini M (2009) Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia. Leuk Res 33(1):162\u2013165","journal-title":"Leuk Res"},{"issue":"4","key":"2173_CR28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0609.2010.01482.x","volume":"85","author":"S Molica","year":"2010","unstructured":"Molica S, Digiesi G, Battaglia C, Cutrona G, Antenucci A, Molica M, Giannarelli D, Sperduti I, Gentile M, Morabito F, Ferrarini M (2010) Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia. Eur J Haematol 85(4):314\u2013320","journal-title":"Eur J Haematol"},{"issue":"10","key":"2173_CR29","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.leukres.2009.03.030","volume":"33","author":"A Bojarska-Junak","year":"2009","unstructured":"Bojarska-Junak A, Hus I, Chocholska S, Wasik-Szczepanek E, Sieklucka M, Dmoszynska A, Rolinski J (2009) BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features. Leuk Res 33(10):1319\u20131327","journal-title":"Leuk Res"},{"issue":"25","key":"2173_CR30","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1182\/blood-2011-01-330852","volume":"117","author":"M Guadagnoli","year":"2011","unstructured":"Guadagnoli M, Kimberley FC, Phan U, Cameron K, Vink PM, Rodermond H, Eldering E, Kater AP, van Eenennaam H, Medema JP (2011) Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas. Blood 117(25):6856\u20136865","journal-title":"Blood"},{"issue":"4","key":"2173_CR31","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1158\/1078-0432.CCR-07-4435","volume":"14","author":"SM Ansell","year":"2008","unstructured":"Ansell SM, Witzig TE, Inwards DJ, Porrata LF, Ythier A, Ferrande L, Nestorov I, Devries T, Dillon SR, Hausman D, Novak AJ (2008) Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin\u2019s lymphoma. Clin Cancer Res 14(4):1105\u20131110","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2173_CR32","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/leu.2011.286","volume":"26","author":"DM Kofler","year":"2012","unstructured":"Kofler DM, Gawlik BB, Elter T, Gianella-Borradori A, Wendtner CM, Hallek M (2012) Phase 1b trial of atacicept, a recombinant protein binding BLyS and APRIL, in patients with chronic lymphocytic leukemia. Leukemia 26(4):841\u2013844","journal-title":"Leukemia"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2173-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2173-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2173-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T14:49:17Z","timestamp":1598194157000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2173-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,22]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2173"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2173-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,22]]}}}